Your browser doesn't support javascript.
loading
Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial.
Gimsing, P; Hjertner, Ø; Abildgaard, N; Andersen, N F; Dahl, T G; Gregersen, H; Klausen, T W; Mellqvist, U-H; Linder, O; Lindås, R; Tøffner Clausen, N; Lenhoff, S.
Afiliação
  • Gimsing P; Department of Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Hjertner Ø; Department of Hematology, St. Olavs University Hospital, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
  • Abildgaard N; Department of Hematology, Odense University Hospital, University of Southern Denmark, Odense, Denmark.
  • Andersen NF; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
  • Dahl TG; Department of Hematology, Rikshospitalet, Oslo, Norway.
  • Gregersen H; Department of Hematology, Aalborg University Hospital, Denmark.
  • Klausen TW; Department of Hematology, Herlev University Hospital, Herlev, Denmark.
  • Mellqvist UH; Department of Hematology, Sahlgrenska University Hospital, Gothenborg, Sweden.
  • Linder O; Department of Hematology, Örebro University Hospital, Örebro, Sweden.
  • Lindås R; Department of Hematology, Haukeland University Hospital, Bergen, Norway.
  • Tøffner Clausen N; Department of Hematology, Herlev University Hospital, Herlev, Denmark.
  • Lenhoff S; Department of Hematology, Skåne University Hospital, Lund, Sweden.
Bone Marrow Transplant ; 50(10): 1306-11, 2015 Oct.
Article em En | MEDLINE | ID: mdl-26121108

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante Autólogo / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Bortezomib / Melfalan Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante Autólogo / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Bortezomib / Melfalan Idioma: En Ano de publicação: 2015 Tipo de documento: Article